Saudi medical innovation – The Milli Chronicle

Sunday, December 14, 2025

Latest:

IndiGo Moves to Restore Passenger Confidence with Customer-Centric Compensation Plan
India Emphasizes Financial Stability and Innovation Balance in Digital Currency Policy
Orkla India Accelerates Growth Strategy with Focus on Quick Meals, Digital Delivery, and Strategic Acquisitions
PNB Housing Finance Signals Stability and Growth with Appointment of Ajai Kumar Shukla as CEO
JSW Energy Strengthens Growth Roadmap with Major Fundraising Plan and New CFO Appointment

Factual Version of a Story

Latest Middle East and North Africa News

NewsDesk Milli Chronicle December 12, 2025 digital health platforms Saudi, G20 healthcare ranking, health access Saudi Arabia, health sector transformation Saudi, long-term health planning Saudi Arabia, medical readiness Saudi Arabia, preventive healthcare Saudi Arabia, Saudi health system reform, Saudi healthcare progress, Saudi life expectancy rise, Saudi medical innovation, Saudi primary care expansion, Saudi public health strategy, Seha Virtual Hospital, Sehhaty app services, sustainable healthcare development, UHC index improvement, Universal Health Coverage Saudi Arabia, Vision 2030 health goals, wellness initiatives Kingdom

Saudi Arabia Rises in Global Universal Health Coverage Index with Strong Vision 2030 Reforms

Riyadh – Saudi Arabia has achieved a significant milestone in global health performance, advancing steadily in the Universal Health Coverage

Latest Middle East and North Africa News

NewsDesk Milli Chronicle October 9, 2025October 9, 2025 advanced medical treatment, ALS clinical outcomes, ALS drug registration, ALS medication Saudi Arabia, ALS treatment, amyotrophic lateral sclerosis, antisense therapy, clinical trials, Health Sector Transformation Program, innovative therapies, Kingdom healthcare development, nerve cell protection, neurodegenerative disease, neurofilament reduction, orphan drugs, patient access, pharmaceutical innovation, protein misfolding therapy, Qalsody approval, rare disease therapy, rare genetic disease treatment, Saudi Arabia healthcare, Saudi FDA, Saudi medical innovation, Saudi patient care, Saudi rare disease patients, SOD1 gene, SOD1 protein reduction., Tofersen, vision 2030

Saudi FDA Approves Qalsody for ALS, Pioneering New Hope for Rare Disease Patients

Riyadh – In a landmark decision for rare disease treatment in Saudi Arabia, the Saudi Food and Drug Authority (SFDA)